secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001193125-24-033973
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRISPR Therapeutics to raise ~$280M via sale of 3.9M common shares at $71.50/share
--------------------------------------------------------------------------------

- Issues 3,916,082 common shares at $71.50 per share to institutional investors.
- Gross proceeds of approximately $280 million; offering not underwritten, direct to investors.
- Shares offered under existing shelf registration statement (Form S-3, filed July 2021).
- Closing expected within ten trading days after February 13, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000119312524033973/0001193125-24-033973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000119312524033973/d788919d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-033973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer